HCW Biologics Inc

NASDAQ HCWB

Data sourced from iex and EODHD
Download Data

HCW Biologics Inc Key Metrics 2019 - 2023

This table shows the Key Metrics for HCW Biologics Inc going from 2019 until 2023. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Accounts Payable Turnover Ratio
R 0.46 5.48 18.33 26.39 0.00
Accounts Receivable Turnover Ratio
R 1.85 16.09 30.83 1.64 -
Asset Coverage Ratio
R - - - - -
Asset Turnover Ratio
R 0.19 0.29 0.15 0.51 0.00
Average Collection Period
R 180.40 16.66 69.87 140.42 -
Book Value Per Share
R 0.37 1.04 1.43 0.39 0.37
Capital Expenditure To Sales
% 218.26 152.86 1.15 4.55 -
Cash Dividend Coverage Ratio
R - - -3.89 - -
Cash Flow Coverage Ratio
R -101.46 -163.12 -21.81 - -
Cash Interest Coverage Ratio
R -79.54 -82.00 -21.72 - -
Cash Per Share
R 0.10 0.62 0.33 0.23 0.30
Cash Ratio
R 0.41 7.55 5.05 8.45 6.90
Cash Return on Assets (CROA)
R -0.79 -0.22 -0.21 -0.68 -0.67
Cash Return on Equity (CROE)
R -1.67 -0.28 -0.21 -0.72 -0.75
Cash Return on Invested Capital (CROIC)
R -1.14 -0.24 -0.21 -0.72 -0.75
Cash Return on Investment (CROI)
R -14.07 -0.92 -0.30 -6.52 -
Cash Taxes
M 5 0 0 4 -
Cash to Debt Ratio
R 0.56 1.74 - - -
Current Assets to Total Assets Ratio
R 0.22 0.73 0.76 0.79 0.80
Current Liabilities Ratio
R 0.31 0.06 0.04 0.07 0.11
Current Liabilities to Total Liabilities Ratio
R 0.58 0.32 1.00 1.00 1.00
Current Ratio
R 0.73 11.52 17.44 12.14 7.53
Days in Inventory
R - 70.20 1,219.75 - -
Days Inventory Outstanding (DIO)
R - 123.11 1,474.88 - -
Days Payable Outstanding (DPO)
R 658.85 108.22 150.18 - -
Days Sales Outstanding (DSO)
R 197.25 22.68 11.84 222.57 -
Debt to Asset Ratio
R 0.23 0.27 - - -
Debt to Capital Ratio
R 0.32 0.26 - - -
Debt to EBITDA Ratio
R -0.26 -0.87 - - -
Debt to Equity Ratio
R 0.48 0.34 - - -
Debt to Income Ratio
R -0.26 -0.87 - - -
Debt to Tangible Net Worth Ratio
R - - - - -
Dividend Coverage Ratio
R - - -4.38 - -
Dividend Payout Ratio
% - - -22.84 - -
Dividend Per Share
R - - 0.08 - -
EBIT to Fixed Assets Ratio
R -1.26 -1.40 -11.95 -3.61 -3.68
EBIT to Total Assets Ratio
R -0.90 -0.32 -0.25 -0.38 -0.73
EBITDA Coverage Ratio
R -86.85 -116.64 -25.38 - -
EBITDA Per Share
R -0.68 -0.41 -0.36 -0.14 -0.28
Equity Multiplier
R 2.12 1.25 1.05 1.07 1.12
Equity to Assets Ratio
R 0.47 0.80 0.96 0.93 0.89
Free Cash Flow Margin
R -10.11 -3.07 -2.69 -2.59 -
Free Cash Flow Per Share
R -0.80 -0.58 -0.31 -0.29 -0.34
Free Cash Flow to Equity (FCFE)
M - - - - -
Free Cash Flow to Firm (FCFF)
M -28 -21 -11 -11 -8
Gross Profit Per Share
R -0.02 0.07 -0.02 0.11 -
Gross Profit to Fixed Assets Ratio
R -0.03 0.24 -0.49 2.54 -
Gross Profit to Tangible Assets Ratio
R - - - - -
Gross Working Capital
M -2 25 36 11 -
Interest Coverage Ratio
R -90.86 -119.05 -26.45 - -
Interest Expense To Sales
% 9.96 1.88 12.33 0.00 -
Inventory Turnover Ratio
R - 2.96 0.25 - -
Invested Capital
M 20 50 53 15 -
Liabilities to Equity Ratio
R 1.12 0.25 0.05 0.07 0.12
Long-Term Debt to Equity Ratio
R 0.47 0.17 - - -
Long-Term Debt to Total Assets Ratio
R 0.22 0.14 - - -
Net Current Asset Value
R -8,647,756.00 24,690,270.00 38,158,782.00 11,147,584.00 6,964,012.00
Net Debt to EBITDA Ratio
R -0.12 1.08 0.91 1.51 1.06
Net Income Before Taxes
R -24,994,281.00 -14,900,703.00 -12,862,468.00 -5,802,201.00 -7,292,921.00
Net Operating Profit After Tax (NOPAT)
R -24,581,976.07 -14,597,481.69 -12,320,372.13 -5,208,496.88 -6,874,571.03
Net Working Capital to Total Assets Ratio
R -0.08 0.66 0.71 0.72 0.69
Non-current Assets to Total Assets Ratio
R 0.78 0.27 0.24 0.21 0.20
Non-current Liabilities to Total Liabilities Ratio
R 0.42 0.68 0.10 0.16 0.37
Operating Cash Flow Per Share
R -0.63 -0.29 -0.31 -0.28 -0.28
Operating Cash Flow To Current Liabilities
R -2.57 -3.51 -4.73 -10.42 -6.35
Operating Cash Flow to Debt Ratio
R -3.49 -0.81 - - -
Operating Cash Flow to Sales Ratio
% -792.25 -154.51 -267.72 -254.44 -
Operating Expense Ratio
% 884.73 262.79 312.81 242.07 -
Operating Income Per Share
R -0.72 -0.42 -0.37 -0.16 -0.30
Operating Income to Total Debt
R -3.99 -1.18 - - -
Payables Turnover
R 0.55 3.37 2.43 - -
Pre-Tax Margin
% -904.96 -224.32 -326.06 -142.07 -
Quick Ratio
R - 11.05 16.49 11.60 -
Research and Development (R&D) Expense Ratio
% 251.06 138.92 199.37 176.97 -
Retained Earnings To Equity Ratio
R -5.24 -1.22 -0.60 -1.16 -1.08
Retention Ratio
% - - 122.84 - -
Return on Assets (ROA)
% -87.66 -31.45 -23.09 -37.54 -71.73
Return on Capital Employed (ROCE)
% -130.11 -34.39 -26.11 -40.46 -81.84
Return on Common Equity
% - -410,329.65 - -1,204,141.04 -1,529,781.36
Return on Equity (ROE)
% -185.67 -39.34 -24.14 -40.15 -80.23
Return on Fixed Assets (ROFA)
% -122.20 -136.26 -1,104.21 -357.79 -360.74
Return on Gross Investment (ROGI)
% -1,562.39 -920.31 -107.25 -361.30 -
Return on Investment (ROI)
% -1,562.39 -129.88 -33.85 -361.30 -
Return on Net Assets (RONA)
% -95.51 -18.89 -13.48 -21.77 -42.40
Return on Net Investment (RONI)
% 531.28 306.07 - - -
Return on Sales (ROS)
% -879.52 -219.02 -301.41 -140.98 -
Return on Tangible Equity (ROTE)
% - - - - -
Return on Total Capital (ROTC)
% -125.51 -29.30 - - -
Revenue Per Share
M 0 0 0 0 0
Sales to Fixed Assets Ratio
R 0.14 0.62 3.66 2.54 0.00
Sales to Operating Cash Flow Ratio
R -0.13 -0.65 -0.37 -0.39 0.00
Sales to Total Assets Ratio
R 0.10 0.14 0.08 0.27 0.00
Sales to Working Capital Ratio
R -1.21 0.22 0.11 0.37 0.00
Selling, General, and Administrative (SG&A) Expense Ratio
% 460.43 123.87 121.37 59.42 -
Short-Term Debt to Equity Ratio
R 0.01 0.17 0.04 0.04 -
Short-Term Debt to Total Assets Ratio
R 0.01 0.14 0.03 0.04 -
Tangible Asset Value Ratio
R - 0.80 0.96 -1.09 -0.96
Tangible Book Value per Share
R - - - - -
Total Debt to Capital Ratio
R 0.32 0.26 - - -
Total Liabilities to Total Assets Ratio
R 0.53 0.20 0.04 0.07 0.11
Working Capital to Current Liabilities Ratio
R -0.27 10.52 16.44 11.14 6.53
Working Capital To Sales Ratio
R -0.82 4.63 9.31 2.72 -
Working Capital Turnover Ratio
R -1.21 0.22 0.11 0.37 0.00

StockViz Staff

September 19, 2024

Any question? Send us an email